EDIL3 and Sepsis: Neonates with sepsis in the group with high serum DEL-1 levels appeared to exhibit lower 28-day mortality rate compared to the group with low serum DEL-1 levels (8.3% vs. 25%, respectively) (Fig. 5b and Supplementary Table 1).